Page last updated: 2024-10-29

ketanserin and Cerebral Cryptococcosis

ketanserin has been researched along with Cerebral Cryptococcosis in 1 studies

Ketanserin: A selective serotonin receptor antagonist with weak adrenergic receptor blocking properties. The drug is effective in lowering blood pressure in essential hypertension. It also inhibits platelet aggregation. It is well tolerated and is particularly effective in older patients.
ketanserin : A member of the class of quinazolines that is quinazoline-2,4(1H,3H)-dione which is substituted at position 3 by a 2-[4-(p-fluorobenzoyl)piperidin-1-yl]ethyl group.

Research Excerpts

ExcerptRelevanceReference
"Treatment of life-threatening cryptococcal meningitis (CM) is highly challenging due to the limited efficacy of the available antifungal drugs."1.72Discovery of Novel Sertraline Derivatives as Potent Anti- ( Ji, C; Li, J; Li, W; Liu, N; Sheng, C; Tu, J; Yang, W; Yun, Z, 2022)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Li, W1
Yun, Z1
Ji, C1
Tu, J1
Yang, W1
Li, J1
Liu, N1
Sheng, C1

Other Studies

1 other study available for ketanserin and Cerebral Cryptococcosis

ArticleYear
Discovery of Novel Sertraline Derivatives as Potent Anti-
    Journal of medicinal chemistry, 2022, 05-12, Volume: 65, Issue:9

    Topics: Antidepressive Agents; Antifungal Agents; Cryptococcus; Cryptococcus neoformans; Humans; Meningitis,

2022